Stay updated on Camostat+Artemisia Annua vs Placebo in COVID-19 Outpatients Clinical Trial
Sign up to get notified when there's something new on the Camostat+Artemisia Annua vs Placebo in COVID-19 Outpatients Clinical Trial page.

Latest updates to the Camostat+Artemisia Annua vs Placebo in COVID-19 Outpatients Clinical Trial page
- CheckyesterdayChange DetectedA sitewide NIH banner announces a website transition and a change in terminology from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check8 days agoChange DetectedThe revision number in the footer of the 403 Forbidden page changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check15 days agoChange DetectedThe site revision displayed on the 403 error page changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check29 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the study details with an access-denied message and preventing viewing the study record.SummaryDifference20%

- Check57 days agoChange DetectedPage revision label updated from v3.6.5 to v3.6.6, indicating a site-wide update. This change does not modify the study content, eligibility criteria, or outcomes presented for the trial.SummaryDifference0.1%

- Check78 days agoChange DetectedThe page shows Revision: v3.6.5, indicating a recent update to the page template or content. This update does not alter the underlying study information.SummaryDifference0.0%

Stay in the know with updates to Camostat+Artemisia Annua vs Placebo in COVID-19 Outpatients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Camostat+Artemisia Annua vs Placebo in COVID-19 Outpatients Clinical Trial page.